OVAMIR

Serial Number 97594340
616

Registration Progress

Application Filed
Sep 16, 2022
Under Examination
Aug 15, 2023
Approved for Publication
Jun 20, 2023
Published for Opposition
Jun 20, 2023
Registered

Trademark Image

OVAMIR

Basic Information

Serial Number
97594340
Filing Date
September 16, 2022
Published for Opposition
June 20, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
616
Status Date
Nov 5, 2025
Application
Pending
Classes
005

Rights Holder

AptamiR Therapeutics, Inc.

03
Address
484 TERRACINA WAY
NAPLES, FL 341191814

Ownership History

AptamiR Therapeutics, Inc.

Original Applicant
03
NAPLES, FL

AptamiR Therapeutics, Inc.

Owner at Publication
03
NAPLES, FL

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

43 events
Date Code Type Description Documents
Nov 19, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 19, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 6, 2025 ALIE A ASSIGNED TO LIE Loading...
Nov 5, 2025 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Nov 5, 2025 PGRR O PETITION GRANTED - RESPONSE RECEIVED Loading...
Sep 18, 2025 ERTP I TEAS RESPONSE TO PETITION DEFICIENCY RECEIVED Loading...
Sep 18, 2025 PINM O INCOMPLETE PETITION NOTICE MAILED Loading...
Aug 27, 2025 ERTP I TEAS RESPONSE TO PETITION DEFICIENCY RECEIVED Loading...
Aug 20, 2025 PINM O INCOMPLETE PETITION NOTICE MAILED Loading...
Aug 18, 2025 APET A ASSIGNED TO PETITION STAFF Loading...
Jul 7, 2025 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Jul 7, 2025 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Jul 7, 2025 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Dec 10, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Dec 10, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Dec 10, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 10, 2024 GNRT O NON-FINAL ACTION E-MAILED Loading...
Dec 10, 2024 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Nov 19, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 19, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Sep 16, 2024 IUAF S USE AMENDMENT FILED Loading...
Nov 19, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 15, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 15, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 16, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 16, 2024 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Sep 16, 2024 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Sep 16, 2024 PETG O PETITION TO REVIVE-GRANTED Loading...
Sep 16, 2024 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Sep 16, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Sep 16, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 14, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 13, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 13, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 13, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 15, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 20, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 20, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 31, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 17, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 17, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 3, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 20, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
First Use Anywhere: Sep 16, 2022
First Use in Commerce: Sep 16, 2022

Classification

International Classes
005